World Health Organization. Global Health Observatory data. https://www.who.int/gho/hiv/en/. Accessed 12 July 2019.
Institute for Health Metrics and Evaluation. GBD Compare. 2017. https://vizhub.healthdata.org/gbd-compare/. Accessed 12 July 2019.
UNAIDS. Fact Sheet. https://www.unaids.org/en/resources/fact-sheet. Accessed 12 July 2019.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.
May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS (London, England). 2014;28(8):1193–202.
Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376(9740):532–9.
Do AN, Rosenberg ES, Sullivan PS, Beer L, Strine TW, Schulden JD, et al. Excess burden of depression among HIV-infected persons receiving medical care in the united states: data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS ONE. 2014;9(3):e92842.
Gowda C, Coppock D, Brickman C, Shaw PA, Gross R. Determinants of HIV transmission risk among HIV-infected persons engaged in care. AIDS Educ Prev. 2016;28(5):440–52.
Simoni JM, Safren SA, Manhart LE, Lyda K, Grossman CI, Rao D, et al. Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav. 2011;15(2):376–88.
Glynn TR, Llabre MM, Lee JS, Bedoya CA, Pinkston MM, O’Cleirigh C, et al. Pathways to health: an examination of hiv-related stigma, life stressors, depression, and substance use. Int J Behav Med. 2019;26:286.
Schuster R, Bornovalova M, Hunt E. The influence of depression on the progression of HIV: direct and indirect effects. Behav Modif. 2012;36(2):123–45.
Bozorgmehr A, Alizadeh F, Ofogh SN, Hamzekalayi MRA, Herati S, Moradkhani A, et al. What do the genetic association data say about the high risk of suicide in people with depression? A novel network-based approach to find common molecular basis for depression and suicidal behavior and related therapeutic targets. J Affect Disord. 2018;229:463–8.
Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients. Results from the medical outcomes study. Jama. 1989;262(7):914–9.
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(8):807–16.
Hunter JC, DeVellis BM, Jordan JM, Sue Kirkman M, Linnan LA, Rini C, et al. The association of depression and diabetes across methods, measures, and study contexts. Clin Diabetes Endocrinol. 2018;4:1.
Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American heart association. Circulation. 2014;129(12):1350–69.
Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA. 2008;300(18):2161–71.
Drudi LM, Ades M, Turkdogan S, Huynh C, Lauck S, Webb JG, et al. Association of depression with mortality in older adults undergoing transcatheter or surgical aortic valve replacement. JAMA Cardiology. 2018;3:191.
Carrico AW, Bangsberg DR, Weiser SD, Chartier M, Dilworth SE, Riley ED. Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons. AIDS (London, England). 2011;25(8):1113–8.
Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43.
Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr (1999). 2008;47(3):384–90.
Mills JC, Harman JS, Cook RL, Marlow NM, Harle CA, Duncan RP, et al. Comparative effectiveness of dual versus single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression. AIDS (London, England). 2017;31(18):2515–24.
Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2012. 2015. http://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-HSSR_MMP_2012.pdf. Accessed 13 Oct 2017.
Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2014 Cycle (June 2014–May 2015). 2016. Contract No.: 17.
Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2013 Cycle (June 2013–May 2014). 2016. Contract No.: 16.
Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2011. 2015. Contract No.: 10.
Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2010. 2014. Contract No.: 9.
Centers for Disease Control and Prevention. Distinguishing public health research and public health nonresearch: Centers for Disease Control and Prevention; 2010. http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf. Accessed 22 June 2015.
Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol Bull. 2017;143(8):783–822.
Beer L, Mattson CL, Bradley H, Skarbinski J. Understanding cross-sectional racial, ethnic, and gender disparities in antiretroviral use and viral suppression among HIV patients in the United States. Medicine. 2016;95(13):e3171.
Hooker K, Phibbs S, Irvin VL, Mendez-Luck CA, Doan LN, Li T, et al. Depression among older adults in the united states by disaggregated race and ethnicity. Gerontologist. 2018. https://doi.org/10.1093/geront/gny159.
Brown MA, Gellatley W, Hoffman A, Dowdell L, Camac A, Francois R, et al. Medical complications of homelessness: a neglected side of men’s health. Int Med J. 2019;49(4):455–60.
Thakarar K, Morgan JR, Gaeta JM, Hohl C, Drainoni ML. Homelessness, HIV, and incomplete viral suppression. J Health Care Poor Underserved. 2016;27(1):145–56.
Park H, Song I, Shin JY. High Prevalence of depression diagnosis among medical aid beneficiaries: a Korean health insurance database study. Asia Pac J Public Health. 2017;29(8):692–7.
Ludema C, Cole SR, Eron JJ, Edmonds A, Holmes GM, Anastos K, et al. Impact of health insurance, ADAP, and income on HIV Viral suppression among US women in the women’s interagency HIV study, 2006–2009. J Acquir Immune Defic Syndr (1999). 2016;73(3):307–12.
Tolson C, Richey LE, Zhao Y, Korte JE, Brady K, Haynes L, et al. Association of substance use with hospitalization and virologic suppression in a Southern academic HIV clinic. Am J Med Sci. 2018;355(6):553–8.
Sowa NA, Bengtson A, Gaynes BN, Pence BW. Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics. J Affect Disord. 2016;192:153–61.
Chhim K, Mburu G, Tuot S, Sopha R, Khol V, Chhoun P, et al. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study. AIDS Res Ther. 2018;15(1):20.
Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015;17(1):530.
Mayston R, Kinyanda E, Chishinga N, Prince M, Patel V. Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: a systematic review. AIDS (London, England). 2012;26(Suppl 2):S117–35.
Mitchell AJ, Lord O, Malone D. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis. Br J Psychiatry. 2012;201(6):435–43.
Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr (1999). 2011;58(2):181–7.
Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institutes of Health, American Academy of HIV Medicine, Association of Nurses in AIDS Care, International Association of Providers of AIDS Care, et al. Recommendations for HIV prevention with adults and adolescents with HIV in the United States. 2014.
Yager J, Faragon J, McGuey L, Hoye-Simek A, Hecox Z, Sullivan S, et al. Relationship between single tablet antiretroviral regimen and adherence to antiretroviral and non-antiretroviral medications among Veterans’ affairs patients with human immunodeficiency virus. AIDS Patient Care STDs. 2017;31(9):370–6.
Truong WR, Schafer JJ, Short WR. Once-daily, single-tablet regimens for the treatment of HIV-1 infection. Pharm Therapeutics. 2015;40(1):44–55.
Beer L, Mattson CL, Bradley H, Shouse RL. Trends in ART prescription and viral suppression among HIV-positive young adults in care in the United States, 2009–2013. J Acquir Immune Defic Syndr (1999). 2017;76(1):e1–6.
Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27(23):2763–74.
Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78(6):613–7.
Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010;170(21):1884–91.
Moise N, Khodneva Y, Jannat-Khah DP, Richman J, Davidson KW, Kronish IM, et al. Observational study of the differential impact of time-varying depressive symptoms on all-cause and cause-specific mortality by health status in community-dwelling adults: the REGARDS study. BMJ Open. 2018;8(1):e017385.
Feigin V. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–602.
Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3(5):415–24.
Mayer KH, Loo S, Crawford PM, Crane HM, Leo M, DenOuden P, et al. Excess clinical comorbidity among HIV-infected patients accessing primary care in US community health centers. Public Health Rep. 2018;133(1):109–18.
Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, et al. Increased risk of myocardial infarction in HIV-infected individuals in North America compared with the general population. J Acquir Immune Defic Syndr. (1999). 2017;75(5):568–76.
Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York city. Ann Intern Med. 2006;145(6):397–406.
American Psychiatric Association. Guideline Watch: Practice guideline for the treatment of patients with HIV/AIDS. 2006. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/hivaids-watch.pdf. Accessed 30 Mar 2018.
American Psychiatric Association. Practice guideline for the treatment of patients with HIV/AIDS. 2000.